Invitrogen™ Human FGF-23 ELISA Kit

Ref.: BL-RE-091784Manufacturer ref.: EH189RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human FGF-23 quantitates human FGF-23 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human FGF-23.

Accession number
Adhr ; FGF ; Fgf23 ; FGF-23 ; FPNF ; Facteur de croissance des fibroblastes ; facteur de croissance des fibroblastes 23 ; peptide terminal C du facteur de croissance des fibroblastes ; peptide terminal N du facteur de croissance des fibroblastes 23 ; HPDR2 ; HYPF ; Phosphatonine ; PHPTC ; Facteur d’induction de l’hypophosphatémie dérivée de tumeurs ; facteur d’induction de l’hypophosphatémie dérivée de tumeurs ; UNQ3027/PRO9828
Dose range
0.3 to 75 ng/mL
Sensitivity of the dosage
0.3 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human FGF-23 quantitates human FGF-23 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human FGF-23.

Human FGF-23 quantitates human FGF-23 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human FGF-23.

The protein encoded by the AREG gene is part of the epidermal growth factor family. FGF family members have extensive mitogen and cell survival activities and participate in various biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumour growth and invasion. The product of this gene inhibits the transport of renal tubular phosphate. This gene was identified by its mutations associated with dominant autosomal hypophosphatemic ricketism, a hereditary phosphate waste disorder. Abnormally high expression of this gene was found in oncogenic hypophosphatemic osteomalacia, a similar phenotypic disease caused by abnormal phosphate metabolism. Mutations of this gene have also been shown to cause a family tumour calcinosis with hyperphosphataemia.

Sensitivity

Sensitivity of dosage: 0.3 ng/mL.

Measurement range

Dose range: 0.3 to 75 ng/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: FGF23.

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17184939
Specifications
Accession numberAdhr; FGF; Fgf23; FGF-23; FPNF; Fibroblast growth factor; fibroblast growth factor 23; fibroblast growth factor C terminal peptide; fibroblast growth factor N terminal peptide 23; HPDR2; HYPF; Phosphatonin; PHPTC; Factor
Dose range0.3 to 75 ng/mL
Sensitivity of the dosage0.3 ng/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9GZV9
Gene symbol(s)FGF23
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetFGF23
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; plasma, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH189RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.